TXMD Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Stats
Dagens volum	24 483.00
Gjennomsnittsvolum	22 872.00
Markedsverdi	21.68M
EPS	$-0.130 ( 2023-11-13 )
Neste inntjeningsdato	( $0 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.54
ATR14	$0.0150 (0.79%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-05	Walker Marlan D	Buy	70 000	Common Stock
2023-12-06	Walker Marlan D	Sell	14 500	Common Stock
2023-12-07	Walker Marlan D	Sell	4 550	Common Stock
2023-12-05	Walker Marlan D	Sell	70 000	Restricted Stock Units
2023-11-15	Rubric Capital Management Lp	Buy	877 192	Common Stock, par value $0.001 per share ("Common Stock")

INSIDER POWER
77.30
Last 94 transactions
Buy: 1 627 514 \| Sell: 264 866

TherapeuticsMD Inc Korrelasjon

10 Mest positive korrelasjoner
BIOC	0.888
YVR	0.88
INVE	0.879
ARIZ	0.871
VERV	0.864
POAI	0.864
ARVL	0.857
ZD	0.854
GMDA	0.837
ATHN	0.836

10 Mest negative korrelasjoner
GRIN	-0.885
DBDR	-0.865
ABIO	-0.862
CATB	-0.86
PPTA	-0.859
AMRK	-0.857
SGRP	-0.855
MOTNU	-0.851
AFINP	-0.849
GALT	-0.849

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

TherapeuticsMD Inc Økonomi

Annual	2023
Omsetning:	$1.30M
Bruttogevinst:	$380 000 (29.19 %)
EPS:	$-0.980

FY	2023
Omsetning:	$1.30M
Bruttogevinst:	$380 000 (29.19 %)
EPS:	$-0.980

FY	2022
Omsetning:	$69.96M
Bruttogevinst:	$68.57M (98.00 %)
EPS:	$-10.35

FY	2021
Omsetning:	$86.95M
Bruttogevinst:	$68.11M (78.33 %)
EPS:	$-0.625

Financial Reports:

No articles found.

TherapeuticsMD Inc

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.